ニューヨークにおけるホジキンリンパ腫の臨床試験
ニューヨーク内の拠点で、ホジキンリンパ腫に関する15件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center @ Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT03618550Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Cornell, New York
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/15更新 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, New York
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/14更新 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT05272384A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Roswell Park Cancer Institute, Buffalo
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06150664Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第3相
16歳〜69歳 · 全性別 · 2026/07/08更新 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- 他9件
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Memorial Sloan Kettering Cancer Center, New York
- University of Rochester Medical Center, Rochester
被験者募集中観察研究
8歳以上 · 全性別 · 2026/05/20更新 · NCT06098430Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
被験者募集中第2相
26歳以下 · 全性別 · 2026/05/14更新 · NCT07566377A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/23更新 · NCT06377566Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
被験者募集中第1/2相
12歳〜70歳 · 全性別 · 2026/04/15更新 · NCT04491370Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中観察研究
18歳以上 · 女性 · 2026/03/04更新 · NCT01788839AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
被験者募集中第2相
1 Day – 30 Years · 全性別 · 2025/08/08更新 · NCT04099966Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- New York Medical College, Vallhala
被験者募集中第2相
3歳〜39歳 · 全性別 · 2025/06/13更新 · NCT05253495Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。